NVAX Crosses Above Average Analyst Target
June 15, 2020 at 10:32 AM EDT
In recent trading, shares of Novavax, Inc. (NVAX) have crossed above the average analyst 12-month target price of $44.57, changing hands for $45.57/share..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.